RRTB PART 2: Rif Resistant TB Fluroquinolone Susceptible Regimens, Nov 2019 South Africa.

In part two of our Drug resistant TB series we will focus on the latest recommended regimens for patients with RIf resistant TB with likely or confirmed Fluroqoquinolone susceptible bacilli. We will describe the latest regimen choices as outlined in the Rifampicin resistant clinical guide released by the NDOH in Nov 2019. See part one of this series for a short overview of the diagnosis and classification as well as the WHO grouping of DRTB drugs available. Dr Madeleine Muller is a Family Physician who works as a doctor at Nkqubela Tb hospital in Mdantsane, Eastern Cape